logo-loader
viewQrons Inc

Full interview: Qrons seeking to find a cure for traumatic brain injuries using a 3D-printable scaffold

Qrons Inc (OTCQB: QRON) CEO Jonah Meer tells Proactive the New York-based biotechnology company is developing two products, one of which involves a 3D-printable scaffold, aimed at helping to treat traumatic brain injuries.

Meer says that traumatic brain injuries are the number one cause of death among young adults in the US, adding that the company is working towards an Investigational New Drug application or a Biologics Licence application for its products to the FDA.

Quick facts: Qrons Inc

Price: 1.45 USD

OTCMKTS:QRON
Market: OTCMKTS
Market Cap: $18.93 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Merck Head of Pacific BD&L sees a 'coming of age' in how the immune system...

Merck & Co (NYSE:MRK) Head of Pacific Business Development & Licensing Hub and President of the MRL Ventures Fund Reza Halse sat down with Proactive at the BIO Investor Forum in San Francisco.  Halse says he's seeing a 'coming of age' in neuroscience, especially seeing an...

2 hours, 22 minutes ago

2 min read